... (original content here) ... ================= END ORIGINAL SINGLE-TABLE LAYOUT ================= -->
Class | Mechanism | Primary Uses | Examples | Side Effects | Key Cautions | Priority |
---|---|---|---|---|---|---|
SSRIs | Block serotonin reuptake β β serotonin |
|
|
π½οΈ GI: nausea, diarrhea Neuro/Psych: insomnia, headache Sexual: dysfunction Other: weight gain, β bleeding risk |
|
|
SNRIs | Block serotonin & NE reuptake |
|
|
π½οΈ GI: nausea Neuro/Psych: insomnia Sexual: dysfunction Other: weight gain, sweating, possible β BP |
|
|
TCAs | Block NE & 5-HT reuptake; also anticholinergic |
|
|
Anticholinergic: dry mouth, constipation β₯ Cardiac: arrhythmias, orthostatic hypotension Other: sedation, weight gain |
|
|
MAOIs | Inhibit MAO β β NE, 5-HT, DA |
|
|
π Hypertensive crisis if tyramine Insomnia, sexual dysfunction, weight gain |
Avoid tyramine foods No SSRIs/SNRIs/TCAs 2-week washout needed |
|
Atypical Antidepressants | Various NE/DA/5-HT effects |
|
|
Mirtazapine: sedation, β appetite, weight gain Bupropion: seizures risk, weight loss Trazodone: sedation |
|
|
Typical Antipsychotics | Block D2 receptors (β dopamine) |
|
|
EPS: dystonia, akathisia, parkinsonism TD: tardive dyskinesia NMS: fever, rigidity |
|
|
Atypical Antipsychotics | Block D2 & 5-HT2A receptors |
|
|
Metabolic: weight gain, dyslipidemia, hyperglycemia β₯ QT prolongation, sedation Clozapine β Agranulocytosis (monitor WBCs)
|
|
Black Box: Clozapine Agranulocytosis
|
Mood Stabilizers | Varies (e.g. Lithium, Valproate, etc.) |
|
|
Lithium: tremor, thyroid dysfunction, renal issues Valproate: weight gain Lamotrigine: rash (SJS risk) |
|
|
Benzodiazepines | β GABA-A receptor β sedation |
|
|
Sedation, respiratory depression, amnesia Dependence/tolerance **Withdrawal** risk if abrupt stop |
|
|
Stimulants | β NE & DA release/reuptake blockade |
|
|
Insomnia, β appetite β weight loss Anxiety, β₯ tachycardia, β BP |
|